Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET

Clinical trial NCT02801591 · UNKNOWN

Trial details

NCT number: NCT02801591
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Poor Ovarian Response

Start date: 2016-02-01
Primary completion: 2017-02-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.